| An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice TP Sheahan, AC Sims, S Zhou, RL Graham, AJ Pruijssers, ML Agostini, ... Science translational medicine 12 (541), eabb5883, 2020 | 1071 | 2020 |
| Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study F Zhang, Z Dou, Y Ma, Y Zhang, Y Zhao, D Zhao, S Zhou, M Bulterys, ... The Lancet infectious diseases 11 (7), 516-524, 2011 | 404 | 2011 |
| β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells S Zhou, CS Hill, S Sarkar, LV Tse, BMD Woodburn, RF Schinazi, ... The Journal of infectious diseases 224 (3), 415-419, 2021 | 289 | 2021 |
| The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation MR Abrahams, SB Joseph, N Garrett, L Tyers, M Moeser, N Archin, ... Science translational medicine 11 (513), eaaw5589, 2019 | 182 | 2019 |
| Primer ID validates template sampling depth and greatly reduces the error rate of next-generation sequencing of HIV-1 genomic RNA populations S Zhou, C Jones, P Mieczkowski, R Swanstrom Journal of virology 89 (16), 8540-8555, 2015 | 133 | 2015 |
| Characterizing HIV-1 splicing by using next-generation sequencing A Emery, S Zhou, E Pollom, R Swanstrom Journal of virology 91 (6), 10.1128/jvi. 02515-16, 2017 | 86 | 2017 |
| Cytosine deamination and the precipitous decline of spontaneous mutation during Earth's history CA Lewis Jr, J Crayle, S Zhou, R Swanstrom, R Wolfenden Proceedings of the National Academy of Sciences 113 (29), 8194-8199, 2016 | 79 | 2016 |
| Accelerated SARS-CoV-2 intrahost evolution leading to distinct genotypes during chronic infection C Chaguza, AM Hahn, ME Petrone, S Zhou, D Ferguson, MI Breban, ... Cell Reports Medicine 4 (2), 2023 | 58 | 2023 |
| Hepatitis B and hepatitis C seroprevalence in children receiving antiretroviral therapy for human immunodeficiency virus-1 infection in China, 2005-2009 S Zhou, Y Zhao, Y He, H Li, M Bulterys, X Sun, Z Dou, M Robinson, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 54 (2), 191-196, 2010 | 58 | 2010 |
| Primer ID informs next-generation sequencing platforms and reveals preexisting drug resistance mutations in the HIV-1 reverse transcriptase coding domain JR Keys, S Zhou, JA Anderson, JJ Eron Jr, LA Rackoff, C Jabara, ... AIDS research and human retroviruses 31 (6), 658-668, 2015 | 49 | 2015 |
| Total daily pill burden in HIV-infected patients in the southern United States S Zhou, K Martin, A Corbett, S Napravnik, J Eron, Y Zhu, B Casciere, ... AIDS patient care and STDs 28 (6), 311-317, 2014 | 42 | 2014 |
| Multi-laboratory comparison of next-generation to sanger-based sequencing for HIV-1 drug resistance genotyping NT Parkin, S Avila-Rios, DF Bibby, CJ Brumme, SH Eshleman, ... Viruses 12 (7), 694, 2020 | 40 | 2020 |
| Picomolar to micromolar: elucidating the role of distal mutations in HIV-1 protease in conferring drug resistance M Henes, GJ Lockbaum, K Kosovrasti, F Leidner, GS Nachum, ... ACS chemical biology 14 (11), 2441-2452, 2019 | 40 | 2019 |
| Deep Sequencing of the HIV-1 env Gene Reveals Discrete X4 Lineages and Linkage Disequilibrium between X4 and R5 Viruses in the V1/V2 and V3 Variable … S Zhou, MM Bednar, CB Sturdevant, BM Hauser, R Swanstrom Journal of virology 90 (16), 7142-7158, 2016 | 36 | 2016 |
| An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 and multiple endemic, epidemic and bat coronavirus TP Sheahan, AC Sims, S Zhou, RL Graham, CS Hill, SR Leist, A Schäfer, ... Biorxiv, 2020.03. 19.997890, 2020 | 32 | 2020 |
| Quantification of the latent HIV-1 reservoir using ultra deep sequencing and primer ID in a viral outgrowth assay SK Lee, S Zhou, PL Baldoni, E Spielvogel, NM Archin, MG Hudgens, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 74 (2), 221-228, 2017 | 31 | 2017 |
| Diversity and tropism of HIV-1 rebound virus populations in plasma level after treatment discontinuation MM Bednar, BM Hauser, S Zhou, JM Jacobson, JJ Eron Jr, I Frank, ... The Journal of Infectious Diseases 214 (3), 403-407, 2016 | 29 | 2016 |
| The HIV-1 latent reservoir is largely sensitive to circulating T cells JA Warren, S Zhou, Y Xu, MJ Moeser, DR MacMillan, O Council, ... Elife 9, e57246, 2020 | 28 | 2020 |
| Prevalence of drug-resistant minority variants in untreated HIV-1–infected individuals with and those without transmitted drug resistance detected by Sanger sequencing DS Clutter, S Zhou, V Varghese, SY Rhee, BA Pinsky, W Jeffrey Fessel, ... The Journal of Infectious Diseases 216 (3), 387-391, 2017 | 26 | 2017 |
| Sequencing the Biology of Entry: The Retroviral env Gene R Swanstrom, WD Graham, S Zhou Viruses, Genes, and Cancer, 65-82, 2017 | 22 | 2017 |
